TY - JOUR
T1 - The impact of blue light in monolayers representing tumorigenic and nontumorigenic cell membranes containing epigallocatechin-3-gallate
AU - Pires, Filipa
AU - Magalhães-Mota, Gonçalo
AU - Geraldo, Vananélia P. N.
AU - Ribeiro, Paulo A.
AU - Oliveira, Osvaldo N.
AU - Raposo, Maria
N1 - info:eu-repo/grantAgreement/FCT/5876/147412/PT#
info:eu-repo/grantAgreement/FCT/5876/147264/PT#
The authors acknowledge the financial support from FEDER, through Programa Operacional Factores de Competitividade COMPETE and Fundação para a Ciência e a Tecnologia through research project grants PEst-OE/FIS/UI0068/2011, GN2 PGN2 TDC/FIS-NAN/0909/2014 and PTDC/QEQ-COM/5904/2014, from CNPq andFAPESP(2013/14262-7) (Brazil).
FP acknowledges the fellowship grant PD/BD/106036/2015 from RABBIT Doctoral Programme (Portugal).
PY - 2020/9
Y1 - 2020/9
N2 - Natural products such as epigallocatechin-3-gallate (EGCG) have been suggested for complementary treatments of cancer, since they lower toxic side effects of anticancer drugs, and possess anti-inflammatory and antioxidant properties that inhibit carcinogenesis. Their effects on cancer cells depend on interactions with the membrane, which is the motivation to investigate Langmuir monolayers as simplified membrane models. In this study, EGCG was incorporated in zwitterionic dipalmitoyl phosphatidyl choline (DPPC) and anionic dipalmitoyl phosphatidyl serine (DPPS) Langmuir monolayers to simulate healthy and cancer cells membranes, respectively. EGCG induces condensation in surface pressure isotherms for both DPPC and DPPS monolayers, interacting mainly via electrostatic forces and hydrogen bonding with the choline and phosphate groups of the phospholipids, according to data from polarization-modulated infrared reflection absorption spectroscopy (PM-IRRAS). Both monolayers become more compressible upon interaction with EGCG, which may be correlated to the synergy between EGCG and anticancer drugs reported in the literature. The interaction with EGCG is stronger for DPPC, leading to stronger morphological changes in Brewster angle microscopy (BAM) images and higher degree of condensation in the surface pressure isotherms. The changes induced by blue irradiation on DPPC and DPPS monolayers were largely precluded when EGCG was incorporated, thus confirming its antioxidant capacity for both types of membrane.
AB - Natural products such as epigallocatechin-3-gallate (EGCG) have been suggested for complementary treatments of cancer, since they lower toxic side effects of anticancer drugs, and possess anti-inflammatory and antioxidant properties that inhibit carcinogenesis. Their effects on cancer cells depend on interactions with the membrane, which is the motivation to investigate Langmuir monolayers as simplified membrane models. In this study, EGCG was incorporated in zwitterionic dipalmitoyl phosphatidyl choline (DPPC) and anionic dipalmitoyl phosphatidyl serine (DPPS) Langmuir monolayers to simulate healthy and cancer cells membranes, respectively. EGCG induces condensation in surface pressure isotherms for both DPPC and DPPS monolayers, interacting mainly via electrostatic forces and hydrogen bonding with the choline and phosphate groups of the phospholipids, according to data from polarization-modulated infrared reflection absorption spectroscopy (PM-IRRAS). Both monolayers become more compressible upon interaction with EGCG, which may be correlated to the synergy between EGCG and anticancer drugs reported in the literature. The interaction with EGCG is stronger for DPPC, leading to stronger morphological changes in Brewster angle microscopy (BAM) images and higher degree of condensation in the surface pressure isotherms. The changes induced by blue irradiation on DPPC and DPPS monolayers were largely precluded when EGCG was incorporated, thus confirming its antioxidant capacity for both types of membrane.
KW - Antioxidant
KW - Blue irradiation
KW - EGCG
KW - Herbal medicine
KW - Langmuir monolayer
UR - http://www.scopus.com/inward/record.url?scp=85085654411&partnerID=8YFLogxK
U2 - 10.1016/j.colsurfb.2020.111129
DO - 10.1016/j.colsurfb.2020.111129
M3 - Article
C2 - 32502833
AN - SCOPUS:85085654411
SN - 0927-7765
VL - 193
JO - Colloids and Surfaces B: Biointerfaces
JF - Colloids and Surfaces B: Biointerfaces
M1 - 111129
ER -